VA
Natera Awarded Contract to Provide Cancer Testing Services to VA
Natera will provide the VA with its Signatera circulating tumor DNA test for minimal residual disease assessment and treatment monitoring.
Biodesix Nabs US Federal Supply Schedule Contract for Lung Cancer Tests
The company's full lung cancer diagnostic menu will be covered for eligible veterans, active-duty military, and their families.
Oncocyte Nets $3M VA Contract for DetermaRx Lung Cancer Prognostic Test
The test will be covered by the VA for five years to determine the risk of recurrence in early-stage lung cancer patients after surgery.
Grail, Veterans Affairs to Evaluate Galleri Cancer Early Detection Test
Grail will make Galleri available to 10,000 veterans, who may then participate in the company's observational REFLECTION study.
Tempus to Provide NGS Cancer Tests to US Department of Veterans Affairs
VA healthcare providers will be able to access Tempus' suite of next-generation sequencing-based cancer tests under a multiyear deal.